Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$207B
| $696M | 1.33% |
25,899,600
+348,200
| +1% | +$9.55M |
|
2
Colgate-Palmolive
CL
$73.6B
| $570M | 1.09% |
7,792,900
-2,088,600
| -21% | -$149M |
|
|
3
Mastercard
MA
$492B
| $474M | 0.9% |
5,384,700
+1,886,800
| +54% | +$180M |
|
4
NetEase
NTES
$81.9B
| $462M | 0.88% |
11,958,500
+1,020,000
| +9% | +$31.7M |
|
|
B
5
Barrick Mining
B
$67.2B
| $373M | 0.71% |
17,475,502
-9,021,000
| -34% | -$161M |
|
|
6
CVS Health
CVS
$120B
| $368M | 0.7% |
3,842,105
+3,647,000
| +1,869% | +$363M |
|
7
VeriSign
VRSN
$26B
| $353M | 0.67% |
4,081,176
-83,124
| -2% | -$7.17M |
|
|
LLTC
8
DELISTED
Linear Technology Corp
LLTC
| $344M | 0.66% |
7,395,600
-149,500
| -2% | -$6.83M |
|
9
Cboe Global Markets
CBOE
$29.5B
| $300M | 0.57% |
4,508,000
+71,300
| +2% | +$4.57M |
|
|
10
Nike
NKE
$61.3B
| $280M | 0.53% |
+5,066,500
| New | +$289M |
|
|
11
Home Depot
HD
$353B
| $262M | 0.5% |
+2,050,200
| New | +$271M |
|
|
BCR
12
DELISTED
CR Bard Inc.
BCR
| $250M | 0.48% |
1,063,200
-292,100
| -22% | -$63.4M |
|
13
Entergy
ETR
$49.7B
| $231M | 0.44% |
5,667,422
+651,622
| +13% | +$25M |
|
14
Duke Energy
DUK
$96.1B
| $230M | 0.44% |
2,677,667
-1,339,300
| -33% | -$107M |
|
|
EMC
15
DELISTED
EMC CORPORATION
EMC
| $228M | 0.43% |
8,380,900
+1,380,500
| +20% | +$37.3M |
|
16
Sempra
SRE
$55.9B
| $223M | 0.42% |
3,907,000
-291,400
| -7% | -$15.4M |
|
17
Edwards Lifesciences
EW
$54B
| $221M | 0.42% |
6,641,400
+1,644,000
| +33% | +$56.2M |
|
18
Domino's
DPZ
$11.8B
| $218M | 0.41% |
1,658,400
-669,600
| -29% | -$85.1M |
|
|
GAS
19
DELISTED
AGL Resources Inc
GAS
| $216M | 0.41% |
3,279,161
+1,278,100
| +64% | +$84M |
|
20
Kinross Gold
KGC
$32.3B
| $204M | 0.39% |
41,769,572
-5,380,302
| -11% | -$25.7M |
|
21
NVIDIA
NVDA
$5.27T
| $193M | 0.37% |
164,211,720
+34,636,000
| +27% | +$35.7M |
|
22
Novartis
NVS
$294B
| $187M | 0.36% |
2,522,827
-1,120,353
| -31% | -$77.4M |
|
23
Herbalife
HLF
$1.23B
| $185M | 0.35% |
6,312,000
+726,600
| +13% | +$21.7M |
|
24
Alaska Air
ALK
$5.4B
| $184M | 0.35% |
3,156,900
-863,600
| -21% | -$59.7M |
|
25
AstraZeneca
AZN
$246B
| $180M | 0.34% |
2,983,050
+141,650
| +5% | +$8.23M |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.